Leon I. Igel, M.D.

Welcome to Northwell Health Physician Partners Smith Institute for Urology at East 63rd Street, where we prioritize your urological health in the heart of New York, NY. Our expert team of urologists is dedicated to providing top-notch care and cutting-edge treatments for all your urological needs.

Prior to becoming a Northwell Health Partner on April 18, 2022, Dr. J. Francois Eid founded in 2001, Advanced Urological Care, PC, a boutique Urology practice entirely focused on the treatment of advanced erectile and voiding dysfunction with implants.Born in Brussels, Dr. Eid received his Bachelor of Science in Bio-Engineering from Brown University in 1976 and his M.D. from The Medical College of Cornell University in 1982. He completed his urological training at the New York Presbyterian Hospital and Memorial Sloan Kettering Cancer Center in 1988. Prior to founding Advanced Urological Care in 2001, Dr. Eid was Associate Professor in the Departments of Urology at both Weill-Cornell and Sloan Kettering (cf. above). During his 11-year tenure at these institutions, Dr. Eid was exposed to the most challenging cases of ED, acquiring a focused, unparalleled surgical experience with complicated penile implants and sphincters.In addition to penile implant surgery, Dr. Eid is skilled at the medical treatment of erectile dysfunction ("impotence"), surgical correction of incontinence with the male sling and artificial urinary sphincter, correction of abnormal penile curvature, and treatment of Peyronie's disease. Though he has participated in all of the advances that are promoting the treatment of ED, including the FDA's approval of penile injection therapy (Caverject) and oral and urethral medications (Viagra, Cialis, MUSE), his main achievement lies in the area of penile implant surgery. He is the inventor of the "No-Touch Technique". Dr. Eid's novel technique places emphasis on infection prevention by avoiding direct and indirect contact with the patient's skin. An accomplished teacher of the penile implant procedure, Dr. Eid gives workshops on these surgical techniques all over the world, including Korea, Japan, Australia, and throughout the United States. His "State of the Art" workshops use multimedia techniques--slides, video clips, and live real-time surgeries. Hundreds of practicing urologists as well as doctors in training (residents) have participated in these events. Dr. Eid is also on the advisory board of American Medical Systems (Boston Scientific), Coloplast and Rigicon, the manufacturers of penile implants. He is an active participant in the improvement and new design of urological prosthetic devices.In the past 44 years, Dr. Eid has accomplished over 8,000 penile prosthesis implants, averaging more than 300 annually with an infection rate of 0.47%, the lowest in the world. He is also the first physician to perform a penile implant on the World Wide Web. You can see a video clip of this procedure utilizing the "No-Touch Technique" as well as interviews of patients with implants online at http://urologicalcare.com.

Dr. Mateo Mejia is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and an Assistant Attending Physician at NewYork-Presbyterian Hospital.Dr. Mejia received his medical degree (M.D.) from the Universidad CES in his hometown of Medellin, Colombia, after which he completed an internal medicine residency at the Jacobi Medical Center/Albert Einstein College of Medicine in the Bronx, NY, where he also served as a Chief Resident. He completed his Hematology and Oncology fellowship at Weill Cornell Medicine/NewYork-Presbyterian Hospital and joined the Hematology and Medical Oncology Division after completing his fellowship training in 2023. During fellowship, Dr. Mejia developed his clinical experience under the mentorship of Dr. Ruben Niesvizky, while pursuing his laboratory research at Dr. Mark Bustoros’ Laboratory, being able to complete both clinical and translational research in the plasma cell malignancy field.Dr. Mejia’s research has focused on the genomic drivers of aggressive forms of myeloma, for which he received the 2022 Conquer Cancer – American Society of Clinical Oncology (ASCO) Young Investigator Award, a prestigious honor only given to 100 of people each year. Additionally, Dr. Mejia was the recipient ofthe 2022 Charles, Lillian and Betty Neuwirth Foundation Fellowship in Oncology award for his project “Genomic Landscape of Multiple Myeloma with Extramedullary Disease”. Dr. Mejia’s research also investigates the connectionof race, ethnicity and myeloma, how myeloma escapes the surveillance of the immune system, as well as how genetic information can be used to develop novel approaches to treat myeloma.